This type of APOE ɛ4−sex interaction has been shown in a biomarker that distinguishes Alzheimer’s disease (tau pathology), and stronger relationships between APOE ɛ4 allele and greater values in biomarkers of Alzheimer’s disease are observed in females (Altmann et al. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.